Efficacy Assessment of Three Non Pharmacological Therapies in Alzheimer's Disease [clinicaltrials:NCT00646269]

Bio2RDF uri

Efficacy Assessment of Three Non Pharmacological Therapies in Alzheimer's Disease [clinicaltrials:NCT00646269]

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

http://bio2rdf.org/clinicaltrials:NCT00646269

Bio2RDF identifier

NCT00646269

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT00646269

http://www.w3.org/2001/XMLSchema#string

identifiers.org URI

NCT00646269

acronym [clinicaltrials_vocabulary:acronym]

ETNA3

http://www.w3.org/2001/XMLSchema#string

actual enrollment [clinicaltrials_vocabulary:actual-enrollment]

640

http://www.w3.org/2001/XMLSchema#integer

arm group [clinicaltrials_vocabulary:arm-group]

NCT00646269 arm group a87ff679a2f3e71d9181a67b7542122c [clinicaltrials_resource:NCT00646269/arm-group/a87ff679a2f3e71d9181a67b7542122c]

NCT00646269 arm group c4ca4238a0b923820dcc509a6f75849b [clinicaltrials_resource:NCT00646269/arm-group/c4ca4238a0b923820dcc509a6f75849b]

NCT00646269 arm group c81e728d9d4c2f636f067f89cc14862c [clinicaltrials_resource:NCT00646269/arm-group/c81e728d9d4c2f636f067f89cc14862c]

NCT00646269 arm group eccbc87e4b5ce2fe28308fd9f2a7baf3 [clinicaltrials_resource:NCT00646269/arm-group/eccbc87e4b5ce2fe28308fd9f2a7baf3]

authority [clinicaltrials_vocabulary:authority]

clinicaltrials_resource:cc78c9e4148db3856c69c47e1171623e

brief summary [clinicaltrials_vocabulary:brief-summary]

ETNA3 is a multicentric ...... progression rate of dementia.

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

Efficacy Assessment of Three Non Pharmacological Therapies in Alzheimer's Disease

http://www.w3.org/2001/XMLSchema#string

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Proportion of progression to the severe stage of Alzheimer's disease (MMSE score of 15 or lower) 2 years [clinicaltrials_resource:35abff7b1b8df0724079a78478ba2fbb]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Proportion of progression to the severe stage of Alzheimer's disease (MMSE score of 15 or lower) 2 years [clinicaltrials_resource:3e8a6ff5dd6bf4d344b952ee00920e0e]

Proportion of progression to the severe stage of Alzheimer's disease (MMSE score of 15 or lower) 2 years [clinicaltrials_resource:47527177fdae873631834f947aec1b82]

Proportion of progression to the severe stage of Alzheimer's disease (MMSE score of 15 or lower) 2 years [clinicaltrials_resource:bcc86b31c68a0e8efa35f580f25e0c5f]

Proportion of progression to the severe stage of Alzheimer's disease (MMSE score of 15 or lower) 2 years [clinicaltrials_resource:bdbd0bf672330f7cda86d2831539a994]

Proportion of progression to the severe stage of Alzheimer's disease (MMSE score of 15 or lower) 2 years [clinicaltrials_resource:d18143fa5f28bf52036a7fea727b0a2d]

Proportion of progression to the severe stage of Alzheimer's disease (MMSE score of 15 or lower) 2 years [clinicaltrials_resource:d9640019ecab8e392871f1123a3cabc1]

collaborator [clinicaltrials_vocabulary:collaborator]

University Hospital, Bordeaux [clinicaltrials_resource:a8c058e55e7725335f4992dc496d5667]

completion date [clinicaltrials_vocabulary:completion-date]

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

detailed description [clinicaltrials_vocabulary:detailed-description]

ETNA3 is a multicentric ...... rden and resource utilization

http://www.w3.org/2001/XMLSchema#string

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT00646269 [clinicaltrials_resource:3d693da58cd1de4a5f7f3f176b08ee1c]

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2008-03-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

has expanded access [clinicaltrials_vocabulary:has-expanded-access]

http://www.w3.org/2001/XMLSchema#string

intervention [clinicaltrials_vocabulary:intervention]

Standard intervention protocol + "Made-to-measure" program [clinicaltrials_resource:116dc4491e0cda2997da7921eb6c523e]

Standard intervention protocol + Reminiscence therapy [clinicaltrials_resource:83668fbe0568d2bd27eb1f3525430916]

Standard intervention protocol + Cognitive training therapy [clinicaltrials_resource:97ef5ac88df926c664a28effd289ee20]

Standard intervention protocol [clinicaltrials_resource:dec10df9d1858627359176ab8c487327]

is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]

http://www.w3.org/2001/XMLSchema#string

keyword [clinicaltrials_vocabulary:keyword]

Dementia ; Alzheimer's Disease ...... therapy ; efficacy assessment

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2013-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

University Hospital, Bordeaux [clinicaltrials_resource:a8c058e55e7725335f4992dc496d5667]

location [clinicaltrials_vocabulary:location]

CH Agen [clinicaltrials_resource:f8ebb51ec776a265948c6ff21e033492]

nct id [clinicaltrials_vocabulary:nct-id]

NCT00646269

http://www.w3.org/2001/XMLSchema#string

number of arms [clinicaltrials_vocabulary:number-of-arms]

http://www.w3.org/2001/XMLSchema#integer

official title [clinicaltrials_vocabulary:official-title]

Efficacy Assessment of Three Non Pharmacological Therapies in Alzheimer's Disease

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

2007/17

http://www.w3.org/2001/XMLSchema#string

overall official [clinicaltrials_vocabulary:overall-official]

Jean-François , Dartigues, MD, PhD [clinicaltrials_resource:72fd77ee29af88644f53c9a56b87c874]

overall status [clinicaltrials_vocabulary:overall-status]

Completed [clinicaltrials_resource:07ca5050e697392c9ed47e6453f1453f]

oversight [clinicaltrials_vocabulary:oversight]

France: Direction Générale de la Santé [clinicaltrials_resource:f45ef1125c22f346a530ba024bd8e444]

phase [clinicaltrials_vocabulary:phase]

Phase 3 [clinicaltrials_resource:8357418e2694434468870b487644532d]

primary completion date [clinicaltrials_vocabulary:primary-completion-date]

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

reference [clinicaltrials_vocabulary:reference]

14583963 [pubmed:14583963]

responsible party [clinicaltrials_vocabulary:responsible-party]

[clinicaltrials_resource:dbd41868ee618d3e64daa1adf8c3a8a0]

source [clinicaltrials_vocabulary:source]

University Hospital, Bordeaux [clinicaltrials_resource:a8c058e55e7725335f4992dc496d5667]

start date [clinicaltrials_vocabulary:start-date]

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT00646269 study design [clinicaltrials_resource:44d1b2953b369890398c3cb383207248]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT00646269

verification date [clinicaltrials_vocabulary:verification-date]

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT00646269

http://www.w3.org/2001/XMLSchema#string

title

Efficacy Assessment of Three Non Pharmacological Therapies in Alzheimer's Disease

@en

inDataset

clinicaltrials_resource:bio2rdf.dataset.clinicaltrials.R3

type

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]